Literature DB >> 19092842

Additive effects of the major risk alleles of IRF5 and STAT4 in primary Sjögren's syndrome.

G Nordmark1, G Kristjansdottir, E Theander, P Eriksson, J G Brun, C Wang, L Padyukov, L Truedsson, G Alm, M-L Eloranta, R Jonsson, L Rönnblom, A-C Syvänen.   

Abstract

Primary Sjögren's syndrome (SS) shares many features with systemic lupus erythematosus (SLE). Here we investigated the association of the three major polymorphisms in IRF5 and STAT4 found to be associated with SLE, in patients from Sweden and Norway with primary SS. These polymorphisms are a 5-bp CGGGG indel in the promoter of IRF5, the single nucleotide polymorphism (SNP) rs10488631 downstream of IRF5 and the STAT4 SNP rs7582694, which tags the major risk haplotype of STAT4. We observed strong signals for association between all three polymorphisms and primary SS, with odds ratios (ORs) >1.4 and P-values <0.01. We also found a strong additive effect of the three risk alleles of IRF5 and STAT4 with an overall significance between the number of risk alleles and primary SS of P=2.5 x 10(-9). The OR for primary SS increased in an additive manner, with an average increase in OR of 1.78. For carriers of two risk alleles, the OR for primary SS is 1.43, whereas carriers of five risk alleles have an OR of 6.78. IRF5 and STAT4 are components of the type I IFN system, and our findings emphasize the importance of this system in the etiopathogenesis of primary SS.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19092842     DOI: 10.1038/gene.2008.94

Source DB:  PubMed          Journal:  Genes Immun        ISSN: 1466-4879            Impact factor:   2.676


  41 in total

1.  A possible genetic association with chronic fatigue in primary Sjögren's syndrome: a candidate gene study.

Authors:  Katrine Brække Norheim; Stephanie Le Hellard; Gunnel Nordmark; Erna Harboe; Lasse Gøransson; Johan G Brun; Marie Wahren-Herlenius; Roland Jonsson; Roald Omdal
Journal:  Rheumatol Int       Date:  2013-09-03       Impact factor: 2.631

2.  Genetics and genomics of Sjögren's syndrome: research provides clues to pathogenesis and novel therapies.

Authors:  Barbara M Segal; Abu N M Nazmul-Hossain; Ketan Patel; Pamela Hughes; Kathy L Moser; Nelson L Rhodus
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2011-04-16

Review 3.  Genome-wide association studies in Sjögren's syndrome: What do the genes tell us about disease pathogenesis?

Authors:  Peter D Burbelo; Kiran Ambatipudi; Ilias Alevizos
Journal:  Autoimmun Rev       Date:  2014-03-18       Impact factor: 9.754

4.  Current Aspects of Pathogenesis in Sjögren's Syndrome.

Authors:  Michael Voulgarelis; Athanasios G Tzioufas
Journal:  Ther Adv Musculoskelet Dis       Date:  2010-12       Impact factor: 5.346

Review 5.  Update on Pathogenesis of Sjogren's Syndrome.

Authors:  Pulukool Sandhya; Biji Theyilamannil Kurien; Debashish Danda; Robert Hal Scofield
Journal:  Curr Rheumatol Rev       Date:  2017

Review 6.  Pathogenetic mechanisms in the initiation and perpetuation of Sjögren's syndrome.

Authors:  Michael Voulgarelis; Athanasios G Tzioufas
Journal:  Nat Rev Rheumatol       Date:  2010-08-03       Impact factor: 20.543

7.  A genome-wide association study in Han Chinese identifies a susceptibility locus for primary Sjögren's syndrome at 7q11.23.

Authors:  Yongzhe Li; Kunlin Zhang; Hua Chen; Fei Sun; Juanjuan Xu; Ziyan Wu; Ping Li; Liuyan Zhang; Yang Du; Haixia Luan; Xi Li; Lijun Wu; Hongbin Li; Huaxiang Wu; Xiangpei Li; Xiaomei Li; Xiao Zhang; Lu Gong; Lie Dai; Lingyun Sun; Xiaoxia Zuo; Jianhua Xu; Huiping Gong; Zhijun Li; Shengquan Tong; Min Wu; Xiaofeng Li; Weiguo Xiao; Guochun Wang; Ping Zhu; Min Shen; Shengyun Liu; Dongbao Zhao; Wei Liu; Yi Wang; Cibo Huang; Quan Jiang; Guijian Liu; Bin Liu; Shaoxian Hu; Wen Zhang; Zhuoli Zhang; Xin You; Mengtao Li; Weixin Hao; Cheng Zhao; Xiaomei Leng; Liqi Bi; Yongfu Wang; Fengxiao Zhang; Qun Shi; Wencheng Qi; Xuewu Zhang; Yuan Jia; Jinmei Su; Qin Li; Yong Hou; Qingjun Wu; Dong Xu; Wenjie Zheng; Miaojia Zhang; Qian Wang; Yunyun Fei; Xuan Zhang; Jing Li; Ying Jiang; Xinping Tian; Lidan Zhao; Li Wang; Bin Zhou; Yang Li; Yan Zhao; Xiaofeng Zeng; Jurg Ott; Jing Wang; Fengchun Zhang
Journal:  Nat Genet       Date:  2013-10-06       Impact factor: 38.330

8.  Loss of the lupus autoantigen Ro52/Trim21 induces tissue inflammation and systemic autoimmunity by disregulating the IL-23-Th17 pathway.

Authors:  Alexander Espinosa; Valerie Dardalhon; Susanna Brauner; Aurelie Ambrosi; Rowan Higgs; Fransisco J Quintana; Maria Sjöstrand; Maija-Leena Eloranta; Joan Ní Gabhann; Ola Winqvist; Birgitta Sundelin; Caroline A Jefferies; Björn Rozell; Vijay K Kuchroo; Marie Wahren-Herlenius
Journal:  J Exp Med       Date:  2009-07-27       Impact factor: 14.307

9.  Genetic risk factors in lupus nephritis and IgA nephropathy--no support of an overlap.

Authors:  Mai Tuyet Vuong; Iva Gunnarsson; Sigrid Lundberg; Elisabet Svenungsson; Lars Wramner; Anders Fernström; Ann-Christine Syvänen; Lieu Thi Do; Stefan H Jacobson; Leonid Padyukov
Journal:  PLoS One       Date:  2010-05-10       Impact factor: 3.240

Review 10.  Immunogenicity and other problems associated with the use of biopharmaceuticals.

Authors:  Michael G Tovey; Christophe Lallemand
Journal:  Ther Adv Drug Saf       Date:  2011-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.